OKE - ONEOK, Inc.

NYSE - NYSE Delayed Price. Currency in USD
72.20
+0.61 (+0.85%)
At close: 4:01PM EST

72.20 0.00 (0.00%)
After hours: 6:55PM EST

Stock chart is not supported by your current browser
Previous Close71.59
Open71.02
Bid72.18 x 800
Ask72.19 x 800
Day's Range71.00 - 72.35
52 Week Range50.26 - 77.21
Volume1,467,671
Avg. Volume1,905,006
Market Cap29.825B
Beta (3Y Monthly)1.12
PE Ratio (TTM)23.91
EPS (TTM)3.02
Earnings DateFeb 24, 2020 - Feb 28, 2020
Forward Dividend & Yield3.66 (5.11%)
Ex-Dividend Date2019-11-01
1y Target Est76.14
  • PR Newswire

    ONEOK to Present at Wells Fargo Midstream and Utility Symposium

    ONEOK, Inc. (NYSE: OKE) will participate in the Wells Fargo Midstream and Utility Symposium Dec. 11-12, 2019, in New York City.

  • Is ONEOK, Inc. (OKE) Going to Burn These Hedge Funds?
    Insider Monkey

    Is ONEOK, Inc. (OKE) Going to Burn These Hedge Funds?

    We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]

  • Oneok (OKE) Up 2.1% Since Last Earnings Report: Can It Continue?
    Zacks

    Oneok (OKE) Up 2.1% Since Last Earnings Report: Can It Continue?

    Oneok (OKE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • PR Newswire

    ONEOK to Participate in the RBC Capital Markets Midstream Conference

    TULSA, Okla. , Nov. 18, 2019 /PRNewswire/ -- ONEOK, Inc. (NYSE: OKE) will participate in the RBC Capital Markets Midstream Conference on Nov. 20, 2019 , in Dallas, Texas . Materials used at the conference ...

  • Is ONEOK, Inc.'s (NYSE:OKE) 20% ROE Better Than Average?
    Simply Wall St.

    Is ONEOK, Inc.'s (NYSE:OKE) 20% ROE Better Than Average?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • UGI Corp's (UGI) Earnings Miss Estimates in Fiscal 2019
    Zacks

    UGI Corp's (UGI) Earnings Miss Estimates in Fiscal 2019

    UGI Corp's (UGI) Q4 revenues decline on a year-over-year basis.

  • ONEOK (OKE) to Benefit From Steady Organic Growth Project
    Zacks

    ONEOK (OKE) to Benefit From Steady Organic Growth Project

    ONEOK (OKE) is poised to gain from long-term fee-based commitments.

  • Atmos Energy (ATO) Q4 Earnings Beat Estimates by a Penny
    Zacks

    Atmos Energy (ATO) Q4 Earnings Beat Estimates by a Penny

    Atmos Energy's (ATO) fiscal Q4 earnings are better than expected, which is attributable to positive rate outcomes.

  • Goldman Sachs Says These 3 Buy-Rated Stocks Are Primed for Growth
    TipRanks

    Goldman Sachs Says These 3 Buy-Rated Stocks Are Primed for Growth

    With the S&P 500 at record highs, investors are facing an unusual problem: too many places to put their money. A strong jobs report and good news on the US-China trade front have helped to boost the markets; as noted by investment bank Goldman Sachs, in the last week of October over $6.1 billion went back into global stock funds.But where is the smart money going? Goldman economist Silvia Ardagna favors US stocks, but he is careful to hedge his recommendation: “The de-escalation of trade tensions between the U.S. and China has triggered the question whether investors have been too negative and there could be some positive surprises.” He adds that the ongoing US-China trade talks, and the good feelings they have engendered, have his wealthy clients eager to get their money working again. And with that background, we can better understand some of the surprising recommendations that have come from Goldman’s financial research team in recent days. Oneok (OKE)Based in Tulsa, Oklahoma, Oneok is a $12 billion dollar-a-year midstream pipeline company for the natural gas industry in the American West. The company provides midstream services – gathering, processing, storing, transporting, and marketing – for natural gas producers in the Mid-Continent, Permian, and Rocky Mountain production regions. Oneok netted $305.5 million in income in 2018.In its last quarterly report, released on October 30, OKE showed EPS in-line with the estimates, at 74 cents. Revenues, however, missed the forecast by 4.2%, coming in at $2.26 billion against the expected $2.36 billion. The revenue miss was impacted by a combination of expenses due to expanded operations and higher operating costs. While cash flow was down roughly 12% year-over-year, cash on hand was up. Oneok had an impressive $673.3 million in cash and cash equivalents available at the end of September, compared to just $12 million nine months earlier.Goldman analyst Michael Lapides notes the company’s mixed results, but also points out that ‘expanded operations’ specifically means two major pipeline projects expected to come on-line next year. Lapides writes, “OKE is in the late stages of a significant capex cycle, with two large-scale pipeline projects expected to ramp up over the next 6-9 months per management, driving stronger returns, and deleveraging... Given OKE’s asset integration and our wet gas production estimates, we believe there is good visibility to volume growth for these two pipeline projects…”In line with his outlook, Lapides upgrades OKE to a Buy rating, and sets an $81 price target, suggesting an upside of 16% to the stock. (To watch Lapides' track record, click here)OKE is not widely covered by the Street’s analyst corps; among those who do cover the stock, however, the consensus is a Moderate Buy. OKE shows an average price target of $79.33, implying room for about 13% upside from the current trading value of $69.77. (See Oneok's stock analysis on TipRanks)Vir Biotechnology (VIR)This biotech research company, founded in 2016 as a clinical-stage immunology company focusing on the eradication of infectious diseases, had its IPO last month. Since then, it is up 12% in the markets; in its first few weeks of trading, volumes have been modest, and the stock has been volatile.Vir is backed by the Gates Foundation, and has two main projects past the pre-clinical testing phase. A hepatitis B treatment, in collaboration with Alnylam, is in Phase 2 testing, while an Influenza A treatment is in Phase 1 testing. Three more drugs, for TB, HIV, and another for Hep-B, are in the pre-clinical phase. The Gates Foundation is supporting the TB and HIV research. For a small biotech, Vir has a varied pipeline with strong potential.As a new company, Vir hasn’t got a long public record to lean on. That hasn’t stopped Goldman Sachs analyst Paul Choi from initiating coverage of the stock with a Buy rating and an aggressive price target of $37, which implies an impressive upside potential of 133%. (To see Choi's track record, click here)In his initiation report, Choi says, “While we acknowledge that much of the pipeline is early stage, we see significant upside to the stock driven primarily by upcoming Phase 2 HBV and influenza data in 2020, which we think could increase investor confidence in VIR’s platform approach to infectious diseases…” Choi acknowledges that this company is in its early stages, and that the clinical research, while promising, has only just begun. He adds, “…we acknowledge that VIR is several years away from the commercial launch of any of its clinical candidates. We therefore anticipate focus will remain on clinical data over the near-term…”How does Choi's bullish bet weigh in against the Street? It appears the analyst is not the only one enthusiastic on this biotech company's prospects, with TipRanks analytics demonstrating VIR as a Strong Buy. Out of 4 analysts polled by TipRanks in the last 3 months, all 4 are bullish. With a return potential of nearly 100%, the stock’s consensus target price stands at $29. (See Vir's stock analysis on TipRanks)Tal Education Group (TAL)And now we get to a Chinese company. TAL, based in Beijing, describes itself as “a leading education and technology enterprise.” The company’s core focus is on improving science and technology education through integration of internet-based tech in the classroom. TAL has had success in China’s tier-1 cities, and is in process of shifting its priorities to the so-called tier-2 cities.TAL trades on the NYSE, where it has shown a 61% year-to-date gain, nearly triple the S&P gain of 22%. In the company’s most recent quarterly release, for Q2 fiscal 2020, it showed a drop in EPS to 2 cents per share, despite a 33% year-over-year gain in revenues to $936 million. The jump in revenue was attributed to a 54% increase in enrolled students from the year-ago quarter. TAL also boosted Q3 guidance by 41%, to $826 million. Shares spiked after the earnings release, gaining 13%.In a recent report, Goldman’s Christine Cho revisited her firm’s earlier review of TAL and upgraded the rating from Neutral to Buy. Cho wrote, “TAL’s learning center (LC) expansion beyond the top 5 cities has become a key focus in its capacity expansion in recent years. In fact, TAL entered 14/13 new cities in FY19/FY1H20, reaching a footprint of 69 cities as of FY1H20, and learning centers in non-top 5 cities have grown to 52% of the total LC base… We strongly view effective penetration into lower-tier cities as key to long term growth…” Cho’s $50 price target on TAL suggests room for a 15% upside. (To watch Cho's track record, click here)The online education company now looks like a very compelling investing opportunity, as TipRanks analytics showcasing TAL as a Strong Buy. (See Tal Education's stock analysis on TipRanks)

  • MoneyShow

    3 Midstream Favorites for Rising Quarterly Payouts

    Before the energy sector bear market that started in late 2014, most energy midstream companies increased their dividends every single quarter, recalls Tim Plaehn, editor of The Dividend Hunter.

  • Top Midstream Energy Stocks: What Analysts Got Wrong
    Market Realist

    Top Midstream Energy Stocks: What Analysts Got Wrong

    Despite stable earnings and dividend growth, MLP stocks are depressed. We look at the top midstream energy stocks’ performance in the past 12 months.

  • Benzinga

    Cramer Gives His Opinion On Okta, Oneok And More

    On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Lendingtree Inc (NASDAQ: TREE ) in this environment. The market doesn't like Okta Inc (NASDAQ: OKTA ) right now, said Cramer. He ...

  • Oneok Shares Could Hit the Gas Soon
    TheStreet.com

    Oneok Shares Could Hit the Gas Soon

    What are Jim Cramer's thoughts on Oneok Inc. , the natural gas liquids systems operator? In this daily bar chart of OKE, below, we can see that prices have worked higher from their late December nadir. The daily On-Balance-Volume (OBV) line has maintained an uptrend from the December low and its rise tells us that buyers of OKE have been more aggressive.

  • 5 Dividend Stocks for an Uncertain Market
    Market Realist

    5 Dividend Stocks for an Uncertain Market

    The ongoing trade war and geopolitical uncertainties are keeping the stock markets volatile. This may attract investors to dividend stocks.

  • National Fuel Gas (NFG) Q4 Earnings Beat, Revenues Up Y/Y
    Zacks

    National Fuel Gas (NFG) Q4 Earnings Beat, Revenues Up Y/Y

    National Fuel Gas' (NFG) fourth-quarter fiscal 2019 earnings benefit from overall increase in production across segments.

  • MDU Resources' (MDU) Earnings and Revenues Rise Y/Y in Q3
    Zacks

    MDU Resources' (MDU) Earnings and Revenues Rise Y/Y in Q3

    Strong operational performance in construction materials and services businesses drives MDU Resources' (MDU) Q3 results.

  • Barrons.com

    Most Companies Raise Their Dividends Once a Year. Here Are 2 That Raise Them Quarterly.

    The boards of publicly traded companies in the U.S. typically declare dividend increases once a year, a longtime practice that many income investors have come to expect. Penske Automotive Group and Oneok have been going quarterly.

  • Thomson Reuters StreetEvents

    Edited Transcript of OKE earnings conference call or presentation 30-Oct-19 3:00pm GMT

    Q3 2019 ONEOK Inc Earnings Call

  • ONEOK (OKE) Posts In-Line Q3 Earnings, Misses on Revenues
    Zacks

    ONEOK (OKE) Posts In-Line Q3 Earnings, Misses on Revenues

    Higher NGL and natural gas volume growth drive ONEOK's (OKE) Q3 earnings.

  • Oneok Inc. (OKE) Q3 Earnings Match Estimates
    Zacks

    Oneok Inc. (OKE) Q3 Earnings Match Estimates

    Oneok (OKE) delivered earnings and revenue surprises of 0.00% and -4.22%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire

    ONEOK Announces Third Quarter 2019 Earnings; Updates 2019 Financial Guidance and Maintains 2020 Outlook

    11% Increase in Net Income Year to Date Announces Completion of Demicks Lake I Natural Gas Processing Plant in the Williston Basin TULSA, Okla. , Oct. 29, 2019 /PRNewswire/ -- ONEOK, Inc. (NYSE: OKE) today ...

  • ONEOK Earnings, Revenue Miss in Q3
    Investing.com

    ONEOK Earnings, Revenue Miss in Q3

    Investing.com - ONEOK (NYSE:OKE) reported third quarter earnings that missed analysts' expectations on Tuesday and revenue that fell short of forecasts.

  • ONE Gas (OGS) Q3 Earnings Miss Estimates, Revenues Rise Y/Y
    Zacks

    ONE Gas (OGS) Q3 Earnings Miss Estimates, Revenues Rise Y/Y

    ONE Gas' (OGS) third-quarter 2019 results gain from new rates and customer growth.

  • Should You Buy ONEOK (OKE) Ahead of Earnings?
    Zacks

    Should You Buy ONEOK (OKE) Ahead of Earnings?

    ONEOK (OKE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Should You Like ONEOK, Inc.’s (NYSE:OKE) High Return On Capital Employed?
    Simply Wall St.

    Should You Like ONEOK, Inc.’s (NYSE:OKE) High Return On Capital Employed?

    Today we are going to look at ONEOK, Inc. (NYSE:OKE) to see whether it might be an attractive investment prospect. In...